Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

Now watching

Next video starts in : 7 Play

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted
Replay video
Up next

Google Invests $300M in SolarCity Fund in Bet on Renewable Energy

Unlock your personal NFL Now stream by signing in to NFL.com

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

by TheStreet 0:59 mins

Jefferies Estimates AbbVie Could Have a Deal if Shire Bid Boosted

by TheStreet 0:59 mins

Analysts at Jefferies are estimating that pharmaceutical company AbbVie could find itself a deal if it sweetens its $46 billion takeover offer for London-listed rival Shire. Jefferies analysts estimate that AbbVie could improve its offer to 55 pounds a share, or $55 billion. That's up from its most recent cash-and-shares offer of just over 46 pounds, which was rejected. Shire has argued that AbbVie's offer undervalues its business. Since the offer, Shire is giving long-range forecasts for its drugs, predicting that its $4.9 billion in sales in 2013 may double to $10 billion by 2020, helped by its successful ADHD treatment.

TheStreet

We The Economy

  1. 6:40

    cave-o-nomics

    14,926 views

  2. 7:38

    Supply & Dance, Man!

    6,104 views

  3. 5:26

    GDP SMACKDOWN

    12,843 views

  4. Lemonade War

    32,932 views

  5. 6:55

    A BEE’S INVOICE; THE HIDDEN VALUE IN NATURE

    2,071 views

  6. 7:06

    Fed Head